Pfizer Inc. (PFE): Price and Financial Metrics
PFE Price/Volume Stats
Current price | $33.94 | 52-week high | $54.93 |
Prev. close | $33.17 | 52-week low | $31.77 |
Day low | $32.76 | Volume | 44,615,196 |
Day high | $33.96 | Avg. volume | 24,666,723 |
50-day MA | $35.09 | Dividend yield | 5.11% |
200-day MA | $39.87 | Market Cap | 191.62B |
PFE Stock Price Chart Interactive Chart >
PFE POWR Grades
- PFE scores best on the Value dimension, with a Value rank ahead of 96.03% of US stocks.
- PFE's strongest trending metric is Growth; it's been moving down over the last 177 days.
- PFE ranks lowest in Growth; there it ranks in the 1st percentile.
PFE Stock Summary
- With a market capitalization of $184,566,418,343, PFIZER INC has a greater market value than 99.09% of US stocks.
- PFIZER INC's stock had its IPO on January 1, 1986, making it an older stock than 93.16% of US equities in our set.
- As for revenue growth, note that PFE's revenue has grown -22.93% over the past 12 months; that beats the revenue growth of merely 11.29% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to PFIZER INC, a group of peers worth examining would be NFLX, SAP, AMGN, CSCO, and BMY.
- Visit PFE's SEC page to see the company's official filings. To visit the company's web site, go to www.pfizer.com.
PFE Valuation Summary
- In comparison to the median Healthcare stock, PFE's EV/EBIT ratio is 6.03% lower, now standing at 10.9.
- PFE's EV/EBIT ratio has moved down 18.5 over the prior 243 months.
Below are key valuation metrics over time for PFE.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
PFE | 2023-09-22 | 2.4 | 1.9 | 8.6 | 10.9 |
PFE | 2023-09-21 | 2.4 | 1.9 | 8.6 | 10.9 |
PFE | 2023-09-20 | 2.4 | 1.9 | 8.8 | 11.1 |
PFE | 2023-09-19 | 2.5 | 1.9 | 8.9 | 11.2 |
PFE | 2023-09-18 | 2.4 | 1.9 | 8.8 | 11.1 |
PFE | 2023-09-15 | 2.5 | 1.9 | 9.0 | 11.2 |
PFE Growth Metrics
- Its 4 year net cashflow from operations growth rate is now at -11.47%.
- The 3 year revenue growth rate now stands at 71.5%.
- Its 5 year cash and equivalents growth rate is now at -46.98%.

The table below shows PFE's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 99,676 | 26,599 | 29,771 |
2022-06-30 | 101,132 | 31,454 | 29,309 |
2022-03-31 | 92,367 | 34,583 | 24,966 |
2021-12-31 | 81,288 | 32,580 | 21,979 |
2021-09-30 | 63,600 | 32,291 | 19,180 |
2021-06-30 | 51,637 | 23,552 | 13,228 |
PFE's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- PFE has a Quality Grade of B, ranking ahead of 88% of graded US stocks.
- PFE's asset turnover comes in at 0.312 -- ranking 146th of 682 Pharmaceutical Products stocks.
- XBIT, NERV, and BLUE are the stocks whose asset turnover ratios are most correlated with PFE.
The table below shows PFE's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-07-04 | 0.312 | 0.704 | 0.149 |
2021-04-04 | 0.265 | 0.763 | 0.116 |
2020-12-31 | 0.247 | 0.793 | 0.099 |
2020-09-27 | 0.282 | 0.799 | 0.083 |
2020-06-28 | 0.288 | 0.799 | 0.181 |
2020-03-29 | 0.307 | 0.799 | 0.200 |
PFE Price Target
For more insight on analysts targets of PFE, see our PFE price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $46.03 | Average Broker Recommendation | 1.8 (Hold) |
Pfizer Inc. (PFE) Company Bio
Pfizer Inc. is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products. Pfizer was founded under its original name, Charles Pfizer & Company, in 1849 in Brooklyn, New York by Charles Pfizer and Charles Erhart. The company operates research and development facilities in United States and the United Kingdom and employs over 78,000 individuals worldwide. Some of the company’s more recognizable brands include Advil, Celebrex, Chantix, Chapstick, Dimetapp, Lipitor, Robitussin, and Viagra. Albert Bourla serves as Pfizer’s Chairman of the Board and Chief Executive Officer and the company is headquartered in New York, New York.
Latest PFE News From Around the Web
Below are the latest news stories about PFIZER INC that investors may wish to consider to help them evaluate PFE as an investment opportunity.
3 Stocks to Buy in October That Could Soar More Than 40% Over the Next 12 Months, According to Wall StreetBioNTech (NASDAQ: BNTX) has turned in a dismal performance so far this year. The average analysts' price target reflects an upside potential of 56%. Granted, not every analyst is all that bullish about BioNTech. |
Could Viatris Stock Help You Become a Millionaire?Viatris' broad portfolio gives the business lots of stability and plenty of opportunities -- but is there enough there for the stock to be a great long-term investment? |
Moderna's Shares Could Take Off if These 2 Things HappenModerna (NASDAQ: MRNA) used to be a stock market star, climbing 1,700% from the start of 2020 through July of 2021. Investors liked that, and it clearly showed in the stock performance. After all, the vaccine is Moderna's only product right now, and demand for it has declined. |
Unveiling Pfizer (PFE)'s Value: Is It Really Priced Right? A Comprehensive GuideA deep dive into Pfizer's current market valuation, financial strength, and growth prospects |
Why Pfizer and BioNTech Stocks Zoomed Higher TodayThe fight against COVID-19 isn't over yet, and the two companies remain very much in the battle. |
PFE Price Returns
1-mo | -5.14% |
3-mo | N/A |
6-mo | -16.51% |
1-year | -19.31% |
3-year | 10.10% |
5-year | -3.75% |
YTD | -31.68% |
2022 | -10.41% |
2021 | 66.69% |
2020 | 3.23% |
2019 | -6.91% |
2018 | 24.82% |
PFE Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Continue Researching PFE
Want to see what other sources are saying about Pfizer Inc's financials and stock price? Try the links below:Pfizer Inc (PFE) Stock Price | Nasdaq
Pfizer Inc (PFE) Stock Quote, History and News - Yahoo Finance
Pfizer Inc (PFE) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...